INSIGHT MOLECULAR DIAGNOSTIC

IMDXNASDAQ

🏆 #3944 by market capEarnings Nov 5US Equity

$3.18▲ $0.02 (+0.63%)

🌅 Pre-market$3.18▲ 0.00%Regular close · extended-hours price shown

🔔

Track IMDX

Get earnings, price moves & breaking news on Telegram

Track

24h▲ 0.6%

7d▲ 11.6%

14d▲ 3.8%

30d▼ 5.8%

ytd▼ 57.7%

1y▼ 44.6%

🏦Market Cap

$104M

Small Cap

📈Revenue Growth (YoY)

-60.8%

Declining

📊Gross Margin

48.3%

Healthy

💵FCF Margin

—

⚖️P/S Ratio

61.5x

Expensive

Otter Score

—

Insufficient data

INSIGHT MOLECULAR DIAGNOSTIC

IMDX

Analyst Ratings

Price

$3.18

Total

Raised

Lowered

Avg PT

$9.75

H / L

$12 / $8

Institution	Action	Rating	Date		Upside
Needham	Reiterated	Buy	2026-08-18	$9.00	+183.00%
Lake Street	Reiterated	Buy	2026-02-17	$12.00	+277.40%
Stephens & Co.	Reiterated	Equal Weight	2025-03-26	—	—
Benchmark	Reiterated	Speculative Buy	2023-08-23	—	—
Piper Sandler	Reiterated	Neutral	2023-08-14	$0.50	−84.30%
Keybanc	Downgraded	Overweight → Sector Weight	2022-03-14	—	—
BTIG	Reiterated	Buy	2020-11-30	—	—
KeyBanc	Reiterated	Overweight	2020-11-10	—	—
Chardan Capital	Downgraded	Buy → Neutral	2020-06-30	—	—
PiperJaffray	Reiterated	Overweight	2019-02-13	—	—
Janney Capital	Reiterated	Buy	2016-03-15	—	—

Institution

Needham

Reiterated · Buy · 2026-08-18

$9.00

+183.00%

Lake Street

Reiterated · Buy · 2026-02-17

$12.00

+277.40%

Stephens & Co.

Reiterated · Equal Weight · 2025-03-26

—

Benchmark

Reiterated · Speculative Buy · 2023-08-23

—

Piper Sandler

Reiterated · Neutral · 2023-08-14

$0.50

−84.30%

Keybanc

Downgraded · Overweight → Sector Weight · 2022-03-14

—

BTIG

Reiterated · Buy · 2020-11-30

—

KeyBanc

Reiterated · Overweight · 2020-11-10

—

Chardan Capital

Downgraded · Buy → Neutral · 2020-06-30

—

PiperJaffray

Reiterated · Overweight · 2019-02-13

—

Janney Capital

Reiterated · Buy · 2016-03-15

—

One row per institution · price target from the firm's latest published target

StockOtter · stockotter.space